Sinopharm Group Co. Ltd. has convened a board meeting for Friday, 21 August 2026 in Shanghai. Directors will review and approve the unaudited interim financial statements covering the six-month period ended 30 June 2026, alongside other routine matters.

The meeting will be chaired by Mr. Jin Bin, who heads a 15-member Board comprising two executive directors, eight non-executive directors and five independent non-executive directors, according to the official notice released on 7 August 2026.

The outcome of the session is expected to provide investors with the company’s latest financial performance indicators for the first half of 2026.